de Zeeuw D - Search Results

1

Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM.

Buter H, Navis G, Dullaart RP, de Zeeuw D, de Jong PE. Buter H, et al. Among authors: de jong pe, de zeeuw d. Nephrol Dial Transplant. 2001 Apr;16(4):771-5. doi: 10.1093/ndt/16.4.771. Nephrol Dial Transplant. 2001. PMID: 11274272 Clinical Trial.

2

Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.

Heeg JE, de Jong PE, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Clin Sci (Lond). 1991 Sep;81(3):367-72. doi: 10.1042/cs0810367. Clin Sci (Lond). 1991. PMID: 1655338 Clinical Trial.

3

Relief of renal artery stenosis: a tool to improve or preserve renal function in renovascular disease?

Kremer Hovinga TK, de Jong PE, van der Hem GK, de Zeeuw D. Kremer Hovinga TK, et al. Among authors: de jong pe, de zeeuw d. Nephrol Dial Transplant. 1990;5(7):481-8. doi: 10.1093/ndt/5.7.481. Nephrol Dial Transplant. 1990. PMID: 2130291 Review. No abstract available.

4

Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.

Heeg JE, de Jong PE, Vriesendorp R, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Am J Nephrol. 1990;10 Suppl 1:94-7. doi: 10.1159/000168201. Am J Nephrol. 1990. PMID: 2175149 Clinical Trial.

5

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1989 Aug;36(2):272-9. doi: 10.1038/ki.1989.190. Kidney Int. 1989. PMID: 2550696 Free article. Clinical Trial.

6

Is the antiproteinuric effect of dipyridamole hemodynamically mediated?

de Jong PE, van der Meer J, van der Hem GK, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. Nephron. 1988;50(4):292-4. doi: 10.1159/000185190. Nephron. 1988. PMID: 3070413

7

Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.

van Paassen P, de Zeeuw D, de Jong PE. van Paassen P, et al. Among authors: de jong pe, de zeeuw d. J Cardiovasc Pharmacol. 1995 Jul;26(1):39-45. doi: 10.1097/00005344-199507000-00007. J Cardiovasc Pharmacol. 1995. PMID: 7564363 Clinical Trial.

8

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Nephrol Dial Transplant. 1995;10(4):497-504. doi: 10.1093/ndt/10.4.497. Nephrol Dial Transplant. 1995. PMID: 7623991 Clinical Trial.

9

Losartan in patients with renal insufficiency.

de Zeeuw D, Gansevoort RT, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. Can J Cardiol. 1995 Aug;11 Suppl F:41F-44F. Can J Cardiol. 1995. PMID: 7664217

10

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. J Hypertens Suppl. 1994 Jul;12(2):S37-42. J Hypertens Suppl. 1994. PMID: 7965264 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters